Physician profile
Mark D Landers
NPI 1952348682
$8,434.30
in general payments reported to CMS, 2019-2025
45 companies · $1,132 in 2025
The $1,132 reported for 2025 was less than what a typical Clinical Cardiac Electrophysiology provider received nationally (typical 2025 total: $2,477).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,362 · 2020: $818 · 2021: $1,025 · 2022: $962 · 2023: $1,647 · 2024: $1,488 · 2025: $1,132.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,267.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,267.09 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $3,070.69 | 2019-2025 | Watchman Flx, Watchman Access System, Watchman |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $495.20 | 2019-2024 | Lifevest |
| Novartis Pharmaceuticals Corporation | $456.32 | 2019-2023 | |
| Janssen Pharmaceuticals, INC | $447.65 | 2019-2024 | Xarelto |
| Biosense Webster, INC. | $357.48 | 2022-2024 | Na, Carto 3, Octaray Mapping Catheter |
| Atricure, INC. | $352.03 | 2019-2025 | Epi-Sense Guided Coagulation System With Visitrax |
| Pfizer INC. | $317.97 | 2019-2025 | |
| E.R. Squibb & Sons, L.L.C. | $287.60 | 2019-2024 | Eliquis |
| Irhythm Technologies, INC. | $281.58 | 2020-2024 | Zio Xt Patch, Zio Monitor |
| Boehringer Ingelheim Pharmaceuticals, INC. | $239.75 | 2019-2022 | |
| Medtronic, INC. | $221.42 | 2021-2025 | Cobalt Dr Mri Surescan, Micra, Pulseselect |
| Amgen INC. | $220.89 | 2019-2022 | |
| Abbott Laboratories | $213.95 | 2019-2025 | Cardiomems, Amplatzer Amulet, Perclose Proglide |
| Cardiva Medical, INC. | $213.33 | 2019-2025 | Savvywire, Cardiva Vascade Mvp Vvcs 6-12f, Optowire |
| Sanofi-Aventis U.S. LLC | $142.12 | 2019-2020 |
Show all 45 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Vital Connect, INC | $94.54 | 2023 | Vitalpatch Rtm |
| Abiomed | $89.25 | 2024-2025 | Impella |
| Braemar Manufacturing, LLC | $74.45 | 2019 | |
| Edwards Lifesciences Corporation | $68.01 | 2020-2023 | Sapien 3 Ultra Resilia |
| Scpharmaceuticals INC. | $61.71 | 2023 | |
| Terumo Medical Corporation | $46.59 | 2019-2025 | Metacross Otw, Angio-Seal, Heartrail |
| Merck Sharp & Dohme LLC | $45.52 | 2021-2023 | Verquvo |
| Cordis US Corp. | $41.33 | 2025 | Mynx Control Venous |
| Impulse Dynamics (USA) INC. | $40.16 | 2021-2022 | |
| Lundbeck LLC | $39.56 | 2019 | |
| Astrazeneca Pharmaceuticals Lp | $38.47 | 2019-2021 | |
| Cook Medical LLC | $38.26 | 2019-2020 | |
| Biotronik INC. | $38.18 | 2019-2022 | |
| Novo Nordisk INC | $34.80 | 2021 | |
| Shockwave Medical, INC | $33.67 | 2025 | |
| Actelion Pharmaceuticals US, INC. | $32.65 | 2024 | Opsumit, Uptravi |
| Ethicon US, LLC | $32.15 | 2025 | Surgicel Nu-Knit |
| Baxter Healthcare | $30.51 | 2023 | Hillrom - Cardiac Ambulatory Monitor |
| Medtronic Vascular, INC. | $26.70 | 2019 | |
| Chiesi USA, INC. | $25.50 | 2022 | |
| Kowa Pharmaceuticals America, INC. | $24.80 | 2020-2021 | |
| Davol INC. | $23.42 | 2021 | |
| Daiichi Sankyo INC. | $23.37 | 2023 | Injectafer |
| Cmp Pharma, INC. | $20.10 | 2021 | |
| Bayer Healthcare Pharmaceuticals INC. | $18.35 | 2021 | |
| Esperion Therapeutics, INC. | $16.62 | 2021 | |
| Kiniksa Pharmaceuticals, Ltd. | $15.15 | 2023 | Arcalyst |
| Philips North America LLC | $14.77 | 2023 | |
| Teleflex LLC | $14.36 | 2024 | Trapliner |
| Bardy Diagnostics, INC. | $13.37 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mark Landers listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.